Skip to content
No picture yet

Flecainide 100 mg – DIN 02534819

Flecainide is Flecainide Acetate 100 mg (tablet), sold in Canada. It is used for atrial fibrillation (irregular heartbeat), fast heartbeat (SVT) and dangerous fast heartbeat. It is supplied by Sanis Health Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Flecainide Acetate 100 mg

Brand
Flecainide
Strength
100 mg
Used for
Atrial fibrillation (irregular heartbeat), fast heartbeat (SVT) and dangerous fast heartbeat
Form
Tablet
Manufacturer
Sanis Health Inc
Drug class
Heart rhythm medicine
Sold in
Canada
DIN
02534819

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Flecainide Acetate pills and guides

What is Flecainide Acetate used for?

Flecainide Acetate is used for atrial fibrillation (irregular heartbeat), fast heartbeat (SVT) and dangerous fast heartbeat.

Medicine type
Heart rhythm medicine
Official uses from the US prescribing label

In patients without structural heart disease, flecainide is indicated for the prevention of

- paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms

- paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms.

Flecainide is also indicated for the prevention of

- documented ventricular arrhythmias, such as sustained ventricular tachycardia (sustained VT), that in the judgment of the physician, are life-threatening.

Use of flecainide for the treatment of sustained VT, like other antiarrhythmics, should be initiated in the hospital. The use of flecainide is not recommended in patients with less severe ventricular arrhythmias even if the patients are symptomatic.

Because of the proarrhythmic effects of flecainide, its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment outweigh the risks.

Flecainide should not be used in patients with recent myocardial infarction (see Boxed WARNINGS ).

Use of flecainide in chronic atrial fibrillation has not been adequately studied and is not recommended (see Boxed WARNINGS ).

As is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of flecainide favorably affects survival or the incidence of sudden death.

From the FDA-approved label on DailyMed (published Aug 17, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02534819.
  • It names Flecainide, Flecainide Acetate 100 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Flecainide by Sanis Health Inc.

In Canada: prescription only.

Ingredients

Active: Flecainide Acetate

Other Flecainide Acetate pills